CRISPR-Based Correction of Monogenic Disease in Patient-Derived Induced Pluripotent Stem Cells. Annals of Stem Cell Research, [S. l.], v. 9, n. 1, p. 17–24, 2026. DOI: 10.5281/zenodo.22274817. Disponível em: https://somatopub.com/index.php/ASCR/article/view/376. Acesso em: 31 oct. 2026.